JP2022522005A5 - - Google Patents
Info
- Publication number
- JP2022522005A5 JP2022522005A5 JP2021550131A JP2021550131A JP2022522005A5 JP 2022522005 A5 JP2022522005 A5 JP 2022522005A5 JP 2021550131 A JP2021550131 A JP 2021550131A JP 2021550131 A JP2021550131 A JP 2021550131A JP 2022522005 A5 JP2022522005 A5 JP 2022522005A5
- Authority
- JP
- Japan
- Prior art keywords
- drug composition
- enteric
- weight ratio
- tbn
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201910143739.0 | 2019-02-27 | ||
| CN201910143739.0A CN111617047B (zh) | 2019-02-27 | 2019-02-27 | 一种含tbn或其盐或其水合物的药物组合物及其制备方法 |
| PCT/CN2019/098709 WO2020173046A1 (zh) | 2019-02-27 | 2019-07-31 | 一种含tbn或其盐或其水合物的药物组合物及其制备方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022522005A JP2022522005A (ja) | 2022-04-13 |
| JP2022522005A5 true JP2022522005A5 (https=) | 2023-10-10 |
| JP7404381B2 JP7404381B2 (ja) | 2023-12-25 |
Family
ID=72238958
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021550131A Active JP7404381B2 (ja) | 2019-02-27 | 2019-07-31 | Ｔｂｎ、又はその塩もしくは水和物を含む薬物組成物及びその製造方法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220168299A1 (https=) |
| EP (1) | EP3932407B1 (https=) |
| JP (1) | JP7404381B2 (https=) |
| CN (1) | CN111617047B (https=) |
| AU (1) | AU2019431238B2 (https=) |
| CA (1) | CA3131558A1 (https=) |
| IL (1) | IL285865A (https=) |
| WO (1) | WO2020173046A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN109893511B (zh) * | 2017-12-11 | 2022-07-12 | 湖北舒邦药业有限公司 | 一种地红霉素肠溶片肠溶包衣、其制备方法以及一种地红霉素肠溶片 |
| CN116023340A (zh) * | 2019-04-01 | 2023-04-28 | 广州喜鹊医药有限公司 | 硝酮嗪晶型、制备方法及应用 |
| CN112516100A (zh) * | 2020-12-31 | 2021-03-19 | 珠海润都制药股份有限公司 | 一种艾司奥美拉唑镁肠溶片及其制备方法 |
| CN116650411A (zh) * | 2022-02-25 | 2023-08-29 | 广州喜鹊医药有限公司 | 一种注射用硝酮嗪药物组合物及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1683345A (zh) * | 2005-02-28 | 2005-10-19 | 杨喜鸿 | 川芎嗪的协同增效药用酸盐及其制备方法 |
| CN101269049B (zh) * | 2008-04-25 | 2012-01-25 | 广东药学院 | 磷酸川芎嗪微孔渗透泵控释片及其制备方法 |
| CN101468970B (zh) * | 2008-04-25 | 2011-05-11 | 暨南大学 | 一种硝酮类化合物及其制备方法和在制药中的应用 |
| CN101987081B (zh) * | 2010-07-16 | 2012-08-08 | 钟术光 | 一种控释制剂 |
| EP3187171B1 (en) * | 2012-04-30 | 2024-09-25 | Tillotts Pharma AG | A delayed release drug formulation |
| CN104922086B (zh) * | 2015-06-21 | 2018-01-16 | 珠海润都制药股份有限公司 | 一种质子泵抑制剂肠溶片的制备方法 |
| CN105963298B (zh) * | 2016-05-06 | 2019-07-09 | 广州喜鹊医药有限公司 | 川芎嗪衍生物硝酮嗪在预防和治疗脑损伤疾病中的应用 |
| CN108653236B (zh) * | 2017-03-31 | 2025-03-25 | 上海惠永药物研究有限公司 | 一种生物膜包载药物纳米晶体的制备方法及其用途 |
| CN107417631A (zh) * | 2017-08-04 | 2017-12-01 | 广州喜鹊医药有限公司 | 一种氘代硝酮嗪化合物及其制备方法和在制药中的应用 |
| CN108815128B (zh) * | 2018-05-25 | 2022-01-07 | 广东药科大学 | 一种磷酸-川芎嗪微孔渗透泵控释片的制备方法 |
-
2019
- 2019-02-27 CN CN201910143739.0A patent/CN111617047B/zh active Active
- 2019-07-31 CA CA3131558A patent/CA3131558A1/en active Pending
- 2019-07-31 WO PCT/CN2019/098709 patent/WO2020173046A1/zh not_active Ceased
- 2019-07-31 JP JP2021550131A patent/JP7404381B2/ja active Active
- 2019-07-31 US US17/434,624 patent/US20220168299A1/en active Pending
- 2019-07-31 EP EP19917480.6A patent/EP3932407B1/en active Active
- 2019-07-31 AU AU2019431238A patent/AU2019431238B2/en active Active
-
2021
- 2021-08-25 IL IL285865A patent/IL285865A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220168255A1 (en) | Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose | |
| BR112020024203A2 (pt) | combinação farmacêutica, composição e formulação contendo ativador de glucoquinase e inibidor de a-glucosidase, métodos de preparação e uso dos mesmos | |
| KR20100129776A (ko) | 왁스를 포함하는 서방형 제형 | |
| JP7404381B2 (ja) | Ｔｂｎ、又はその塩もしくは水和物を含む薬物組成物及びその製造方法 | |
| BR102016010170A2 (pt) | Stabilized pharmaceutical composition of prolonged release containing antidepressives | |
| JP2022522005A5 (https=) | ||
| KR102197465B1 (ko) | 디메틸푸마르산염을 함유한 장용성 정제 | |
| US20100256088A1 (en) | Low dose therapy for treating viral infections | |
| JP2021534189A (ja) | Ａｇ１０の製剤 | |
| EP2416761B1 (de) | Desfesoterodin in form eines weinsäuresalzes | |
| US20100172984A1 (en) | tablet dosage form comprising cetirizine and pseudoephedrine | |
| WO2017101858A1 (zh) | 环苄普林之延释剂型 | |
| CN116036079B (zh) | 一种复合物的药物组合物及其制备方法 | |
| US20080081069A1 (en) | Novel controlled release formulations of divalproex sodium | |
| DE102021119130A1 (de) | Ethylcellulose-beschichtete Partikel enthaltend ein Salz aus Tapentadol und Phosphorsäure | |
| CN117064862B (zh) | 一种伊布替尼肠溶片及其制备方法 | |
| AU2022426506B2 (en) | A solid pharmaceutical composition | |
| KR20200067406A (ko) | 베포타스틴의 방출 제어형 경구 제제 | |
| US20050064029A1 (en) | Stable pharmaceutical composition | |
| JP2020189815A (ja) | デュロキセチン製剤およびその安定化方法 | |
| EP3057580A1 (de) | Pharmazeutische darreichungsformen enthaltend natrium-1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1h-1,2,3-triazol-1-yl)-1h-pyrazol-5-olat | |
| HK40009517A (en) | Pharmaceutical composition containing dimethyl fumarate for administration at a low daily dose |